Biogen (BIIB) Current Taxes (2016 - 2025)
Historic Current Taxes for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $114.8 million.
- Biogen's Current Taxes fell 7906.26% to $114.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $114.8 million, marking a year-over-year decrease of 7906.26%. This contributed to the annual value of $114.8 million for FY2025, which is 7906.26% down from last year.
- Biogen's Current Taxes amounted to $114.8 million in Q4 2025, which was down 7906.26% from $103.3 million recorded in Q3 2025.
- Biogen's 5-year Current Taxes high stood at $626.1 million for Q1 2025, and its period low was $103.3 million during Q3 2025.
- Its 5-year average for Current Taxes is $269.9 million, with a median of $240.6 million in 2022.
- Data for Biogen's Current Taxes shows a peak YoY increase of 17080.45% (in 2025) and a maximum YoY decrease of 7930.27% (in 2025) over the last 5 years.
- Over the past 5 years, Biogen's Current Taxes (Quarter) stood at $174.7 million in 2021, then skyrocketed by 48.77% to $259.9 million in 2022, then dropped by 0.96% to $257.4 million in 2023, then skyrocketed by 113.01% to $548.3 million in 2024, then plummeted by 79.06% to $114.8 million in 2025.
- Its Current Taxes stands at $114.8 million for Q4 2025, versus $103.3 million for Q3 2025 and $114.8 million for Q2 2025.